The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative: Jnci-Journal of the National Cancer Institute

E. Zikos, C. Coens, C. Quinten, D.E. Ediebah, F. Martinelli, I. Ghislain, M.T. King, C. Gotay, J. Ringash, G. Velikova, B. Reeve, E. Greimel, C.S. Cleeland, H. Flechtner, M. J. B. Taphoorn, J. Weis, J. Schmucker-von Koch, Mirjam A. G. Sprangers, A. Bottomley, Probe Eortc

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: The European Organisation for Research and Treatment of Cancer (EORTC) Patient-Reported Outcomes and Behavioural Evidence (PROBE) initiative was established to investigate critical topics to better understand health-related quality of life (HRQOL) of cancer patients and to educate clinicians, policy makers, and healthcare providers. Methods: The aim of this paper is to review the major research outcomes of the pooled analysis of HRQOL data along with the clinical data. We identified 30 pooled EORTC randomized controlled trials (RCTs), 18 NCIC-Clinical Trials Group RCTs, and two German Ovarian Cancer Study Group RCTs, all using the EORTC QLQ-C30. All statistical tests were two-sided. Results: Evidence was found that HRQOL data can offer prognostic information beyond clinical measures and improve prognostic accuracy in cancer RCTs (by 5.9%-8.3%). Moreover, models that considered both patient-and clinician-reported scores gained more prognostic overall survival accuracy for fatigue (P
Original languageEnglish
Pages (from-to)8
Number of pages1
JournalJournal of the National Cancer Institute
Volume108
DOIs
Publication statusPublished - 2016

Cite this